Bacterial sensitivity to fosfomycin in pregnant women with urinary infection

Brazilian Journal of Infectious Diseases

Volumn 19, Issue 3, 2015, Pages 319-323

  Souza, Rodrigo Batista ^a   Trevisol, Daisson José ^a,b   Schuelter Trevisol, Fabiana ^a,b  

^a UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

^b HOSPITAL NOSSA SENHORA DA CONCEIÇÃO   (Brazil)

Author keywords

Fosfomycin; Microbial sensitivity tests; Pregnancy; Urinary tract

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CEFADROXIL; CEFALEXIN; CEFALOTIN; CEFAZOLIN; CEFEPIME; CEFOXITIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; ERTAPENEM; FOSFOMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; NALIDIXIC ACID; NITROFURANTOIN; NORFLOXACIN; OXACILLIN; PENICILLIN G; PIPEMIDIC ACID; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE; UNINDEXED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIUM COLONY; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BRAZIL; ESCHERICHIA COLI; FEMALE; HUMAN; IN VITRO STUDY; NONHUMAN; PREGNANT WOMAN; STAPHYLOCOCCUS AUREUS; TREATMENT DURATION; URINALYSIS; URINARY TRACT INFECTION; URINE CULTURE; CLASSIFICATION; CROSS-SECTIONAL STUDY; DRUG EFFECTS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BRAZIL; CROSS-SECTIONAL STUDIES; FEMALE; FOSFOMYCIN; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 84930088983     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2014.12.009     Document Type: Article

References (22)

1. Fiadjoe P., Kannan K., Rane A. Maternal urological problems in pregnancy. Eur J Obstet Gynecol Reprod Biol 2010, 152:13-17.
2. Herráiz M.A., Hernández A., Asenjo E., Herráiz I. Urinary tract infections in pregnancy. Enferm Infecc Microbiol Clin 2005, 23:40-46.
3. Figueiredo A., Gomes G., Campos A. Urinary tract infection in pregnancy: diagnosis, treatment and prevention. Acta Obstet Ginecol Port 2012, 6:124-133.
4. MacLeon A.B. Urinary tract infection in pregnancy. Int J Antimicrob Agents 2001, 17:273-276.
5. Krcmery S., Hromec J., Demesova D. Treatment of lower urinary tract infection in pregnancy. Int J Antimicrob Agents 2001, 17:279-282.
6. Unlu B.S., Yildiz Y., Keles I., et al. Urinary tract infection in pregnant population, which empirical antimicrobial agent should be specified in each of the three trimesters?. Ginekol Pol 2014, 85:371-376.
7. Naber K.G., Schito G., Botto H., Palou J., Mazzei T. Surveillance study in Europe and Brazil on clinical aspects and antimicrobial resistance epidemiology in females with cystitis (ARESC): implications for empiric therapy. Eur Urol 2008, 54:1164-1175.
8. Ejrnæs K. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli. Dan Med Bull 2011, 58:B4187.
9. Silva A., Machado P., Rodrigues V., Duarte A. Bactérias uropatogênicas identificadas de cistites não complicadas de mulheres na comunidade. Acta Urol 2008, 25:9-14.
10. Correia C., Costa E., Peres A., Alves M., Pombo G., Estevinho L. Etiologia das infecções do tracto urinário e sua susceptibilidade aos antimicrobianos. Acta Med Port 2007, 20:543-549.
11. Maraki S., Samonis G., Rafailidis P.I., Vouloumanou E.K., Mavromanolakis E., Falagas M.E. Susceptibility of urinary tract bacteria to fosfomycin. Antimicrob Agents Chemother 2009, 53:4508-4510.
12. Hernández M.S., Garcia J.A., Muñoz J.L. Actividad in vitro de fosfomicina frente a enterobacterias de origen urinário productoras de betalactamasas de espectro extendido. Rev Esp Quimioter 2009, 22:25-29.
13. Palou J., Pigrau C., Molina I., Ledesma J.M., Ângulo J. Etiologia y sensibilidad de los uropatógenos identificados en infecciones urinarias bajas no complicadas de la mujer (Estudio ARESC): implicaciones en la terapia empírica. Med Clin (Barc) 2011, 136:1-7.
14. Andrade J., Lopes C.M.C., Silva D.C., Ribeiro M.G.C., Souza J.E.M.R. Emprego de fosfomicina trometamol em dose única para tratamento de infecções não complicadas do trato urinário em cardiopatas, gestantes e não gestantes: estudo controlado. J Bras Ginecol 1994, 104:345-351.
15. Usta T.A., Dogan O., Ates U., Yucel B., Onar Z., Kaya E. Comparison of single-dose and multiple-dose antibiotics for lower urinary tract infection in pregnancy. Int J Gynaecol Obstet 2011, 114:229-233.
16. Michalopoulos A.S., Livaditis I.G., Gougoutas V. The revival of fosfomycin. Int J Infect Dis 2011, 15:732-739.
17. Estebanez A., Pascual R., Gil V., Ortiz F., Santibáñes M., Barba C.P. Fosfomycin in a single dose versus a 7-day course of amoxicillin-clavulanate for the treatment of asymptomatic bacteriuria during pregnancy. Eur J Clin Microbiol Infect Dis 2009, 28:1457-1464.
18. Lee M., Bozzo P., Einarson A., Koren G. Urinary tract infections in pregnancy. Can Fam Physician 2008, 54:853-854.
19. Wagenlehner F.M., Hoyme U., Kaase M., Fünfstück R., Naber K.G., Schmiemann G. Uncomplicated urinary tract infections. Dtsch Arztebl Int 2011, 108:415-423.
20. Nahum G.G., Uhl K., Kennedy D.L. Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks. Obstet Gynecol 2006, 107:1120-1138.
21. Shrim A., Garcia-Bournissen F., Koren G. Pharmaceutical agents and pregnancy in urology practice. Urol Clin North Am 2007, 34:27-33.
22. Fircanis S., McKay M. Recognition and management of extended spectrum beta lactamase producing organisms (ESBL). Med Health R I 2010, 93:161-162.